Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.51
(
-1.18%
)
Bitcoin
81,026.46
(
0.68%
)
News Focus
News Focus
Post# of 257553
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122973
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 256095

Tuesday, 11/04/2025 6:24:56 PM

Tuesday, November 04, 2025 6:24:56 PM

Post# of 257553
(ENTA)—PFE terminated_an_early-stage RSV therapeutic_called PF-07941944 as part of its pipeline pruning disclosed today:

https://www.fiercebiotech.com/biotech/pfizers-parade-pipeline-cuts-seagen-biontech-and-mash-programs-among-11-axed

Note: PF-07941944 should not be confused with Sisunatovir, the RSV therapeutic that PFE acquired from Reviral and terminated following a phase-3 trial.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today